Monitor Moderna's upcoming quarterly earnings for any operational updates tied to the new COO's mandate, particularly around manufacturing scale-up for intismeran autogene. The retirement of the CTO is orderly with a successor already in place, so no disruption expected.
Price Chart
Executive Summary
Moderna announced the appointment of Juan Andres as Chief Operating Officer, a newly created role, effective October 5, 2026, and the retirement of Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer. The new COO role is framed as supporting the company's expansion into oncology and its growing infectious disease franchise, including the potential launch of intismeran autogene. This is a routine executive leadership change with no financial data or guidance provided.
Key Facts
- Juan Andres appointed as COO, effective October 5, 2026, reporting to CEO Stephane Bancel.
- Andres previously served at Moderna from 2017 to 2023, including as Chief Technical Operations and Quality Officer.
- Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer, is retiring.
- Andres will receive an initial annual base salary of $800,000 and is eligible for an annual cash bonus with a target of 90% of base salary.
- Andres will receive a new hire equity award valued at $5,000,000 with a four-year vesting period.
- The press release highlights Moderna's preparation for the potential launch of intismeran autogene and recent FDA approval of its seasonal flu vaccine.
Financial Impact
No financial impact disclosed. Compensation details for the new COO are routine and immaterial relative to Moderna's market cap.
Risk Factors
- No material risks identified from this filing; executive transitions are routine.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-408289 |
| Document: d18337dex991.htm | 0001193125-26-408289 |
| Document: 0001193125-26-408289-index-headers.html | 0001193125-26-408289 |
| Document: 0001193125-26-408289-index.html | 0001193125-26-408289 |
| Document: 0001193125-26-408289.txt | 0001193125-26-408289 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | ANALYST-DOWNGRADE | $192.70 | awaiting T+1 | — | $207.97 (−7.92%) |
Sep 30, 2026 27d ago | 8-K | $192.57 $188.94 | ▼ −1.89% | ▼ −2.06% | $207.97 (+8.00%) |
Sep 30, 2026 27d ago | ANALYST-DOWNGRADE | — | awaiting T+1 | — | — |
Sep 16, 2026 5w ago | Insider Cluster | $158.07 $154.04 | ▲ +2.55% | ▲ +2.43% | $207.97 (−31.57%) |
Sep 3, 2026 7w ago | ANALYST-DOWNGRADE | $148.87 $145.55 | ▲ +2.23% | ▲ +1.84% | $207.97 (−39.70%) |
Aug 31, 2026 8w ago | Court Ruling | $154.27 $150.81 | ▲ +2.24% | ▲ +2.69% | $207.97 (−34.81%) |
Aug 25, 2026 9w ago | ANALYST-UPGRADE | $158.83 $149.66 | ▼ −5.77% | ▼ −5.80% | $207.97 (+30.94%) |
Aug 19, 2026 9w ago | ANALYST-UPGRADE | $174.38 $133.32 | ▼ −23.55% | ▼ −22.71% | $207.97 (+19.26%) |
Aug 5, 2026 11w ago | 144 | $56.26 $53.86 | ▲ +4.26% | ▲ +4.10% | $207.97 (−269.69%) |
Jul 31, 2026 12w ago | 8-K | $54.82 $55.08 | ▲ +0.48% | ▼ −0.93% | $207.97 (+279.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers